Cite
Alkan A, Cenikli U, Uylaş S, et al. Treatment-refractory paraneoplastic opsoclonus-myoclonus syndrome in a patient with small-cell carcinoma of the lung. J Oncol Pharm Pract. 2019;26(1):209-211doi: 10.1177/1078155219831366.
Alkan, A., Cenikli, U., Uylaş, S., Yılmaz, M., Çakır, T., Çetinkaya, H., Kıran, A., & Tanrıverdi, �. �. (2020). Treatment-refractory paraneoplastic opsoclonus-myoclonus syndrome in a patient with small-cell carcinoma of the lung. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 26(1), 209-211. https://doi.org/10.1177/1078155219831366
Alkan, Ali, et al. "Treatment-refractory paraneoplastic opsoclonus-myoclonus syndrome in a patient with small-cell carcinoma of the lung." Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners vol. 26,1 (2020): 209-211. doi: https://doi.org/10.1177/1078155219831366
Alkan A, Cenikli U, Uylaş S, Yılmaz M, Çakır T, Çetinkaya H, Kıran A, Tanrıverdi Ö. Treatment-refractory paraneoplastic opsoclonus-myoclonus syndrome in a patient with small-cell carcinoma of the lung. J Oncol Pharm Pract. 2020 Jan;26(1):209-211. doi: 10.1177/1078155219831366. Epub 2019 Feb 22. PMID: 30791855.
Copy
Download .nbib